2025-07-28 - Analysis Report
Okay, here's an analysis of Colgate-Palmolive (CL) based on the provided data. The report is structured with numerical summaries followed by analysis, and is written in English.

## Colgate-Palmolive (CL) Stock Analysis

Colgate-Palmolive Co. is a global consumer products company focused on household, health care, and personal care products.

**1. Performance vs. S&P 500 (VOO):**

*   **CL Cumulative Return:** 14.47%
*   **VOO Cumulative Return:** 99.66%
*   **Absolute Divergence:** -84.2
*   **Relative Divergence:** 0.2 (on a scale where the minimum divergence is 0 and the maximum is 100)

**Analysis:** Colgate-Palmolive has significantly underperformed the S&P 500 (VOO) over the period for which cumulative returns are calculated. The large negative divergence (-84.2) indicates substantial underperformance. The relative divergence of 0.2 suggests that this underperformance is near the lowest end of its historical range.

**Alpha/Beta Analysis:**

| Year       | CAGR  | MDD   | Alpha   | Beta   | Cap(B) |
|------------|-------|-------|---------|--------|--------|
| 2015-2017  | 13.0% | 4.5%  | -16.0%  | 0.0    | 61.1   |
| 2016-2018  | -11.0% | 65.2% | -29.0%  | 0.1    | 48.2   |
| 2017-2019  | 7.0%  | 65.2% | -22.0%  | 0.1    | 55.8   |
| 2018-2020  | 18.0% | 65.2% | -2.0%   | 0.6    | 69.3   |
| 2019-2021  | 30.0% | 58.6% | -19.0%  | 0.7    | 69.2   |
| 2020-2022  | 7.0%  | 69.0% | 5.0%    | 0.7    | 63.9   |
| 2021-2023  | 6.0%  | 69.0% | -12.0%  | 0.8    | 64.6   |
| 2022-2024  | 13.0% | 69.0% | -12.0%  | 0.8    | 73.7   |
| 2023-2025  | 1.0%  | 70.6% | -50.0%  | 0.3    | 71.3   |

**Analysis:**

*   **Alpha:** The consistently negative alpha values, especially the recent -50.0%, indicate that Colgate-Palmolive has generally underperformed its expected return based on its beta and the market's return.  In the most recent period, this underperformance is particularly pronounced.
*   **Beta:** The beta values are generally low, indicating that the stock is less volatile than the overall market.  Beta has fluctuated, recently dipping to 0.3.
*   **CAGR & MDD:** CAGR (Compound Annual Growth Rate) varies significantly across the periods. MDD (Maximum Drawdown) has been high recently, which may indicate periods of increased volatility.
*   **Capitalization(B):** has remained relatively stable over the years.

**2. Recent Price Action:**

*   **Current Price:** 87.93
*   **Previous Close:** 88.45
*   **Change:** -0.59
*   **5-Day Moving Average:** 88.10
*   **20-Day Moving Average:** 89.66
*   **60-Day Moving Average:** 90.20

**Analysis:** The current price is slightly below the previous close, and all moving averages are trending downward. This suggests short-term negative price momentum.

**3. Technical Indicators:**

*   **Market Risk Indicator (MRI):** 0.3301 (Low Risk)
*   **RSI:** 22.12 (Oversold)
*   **PPO:** -0.1174
*   **Hybrid Signal:** cash_70%_Sell 69.9% of holdings (1169 shares - Caution - MRI:0.34)
*   **Recent (20-day) Relative Divergence Change:** 0.2 (+) - Short-term increase
*   **Expected Return (%):** -3601.6

**Analysis:**

*   **MRI:** The Market Risk Indicator suggests a low-risk environment, which might be misleading given the other negative indicators specific to CL.
*   **RSI:** The Relative Strength Index (RSI) is in oversold territory (below 30), suggesting a potential for a price rebound.
*   **PPO:** PPO(Percentage Price Oscillator)가 -0.1174이므로 약세 추세를 나타낸다.
*   **Hybrid Signal:** The hybrid signal recommends a significant reduction in holdings (nearly 70%) and a high cash position (70%).
*   **Recent (20-day) Relative Divergence Change:** The small positive change in divergence suggests a potential for short-term improvement relative to the S&P 500, but it's a weak signal considering the overall divergence.
*   **Expected Return (%):**  The extremely negative expected return (-3601.6%) is very unusual and warrants further investigation. This value seems unrealistic and might be an error in the data. If accurate, it signals a deeply concerning outlook for Colgate-Palmolive compared to the S&P 500.
*   **Price Change:** The minor price change from the previous close (-0.59) doesn't indicate a major volatility event.

**4. Recent News & Significant Events:**

*   Volatility due to recent news, earnings reports, or executive actions.
*   Analyst discussions regarding recent performance and outlook.
*   Focus on both risks and opportunities by market experts.
*   General news coverage regarding business developments and regulatory changes.

**Analysis:** The news headlines point to increased scrutiny and volatility related to Colgate-Palmolive, likely driven by performance concerns, earnings, and broader economic conditions. Investors should monitor these developments closely.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-04-25 | 0.85 | 4.91 B$   |
| 2024-10-25 | 0.90 | 5.03 B$   |
| 2024-07-26 | 0.89 | 5.06 B$   |
| 2024-04-26 | 0.83 | 5.07 B$   |
| 2025-04-25 | 0.83 | 5.07 B$   |

**Analysis:**

*   **EPS:** Earnings per share (EPS) has fluctuated.
*   **Revenue:** Revenue has decreased from 5.07 B$ to 4.91B$.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-03-31   | $4.91B     | 60.82%        |
| 2024-12-31   | $4.95B     | 60.30%        |
| 2024-09-30   | $5.03B     | 61.08%        |
| 2024-06-30   | $5.06B     | 60.62%        |
| 2024-03-31   | $5.07B     | 60.00%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE       |
|--------------|------------|-----------|
| 2025-03-31   | $0.36B     | 190.08%   |
| 2024-12-31   | $0.21B     | 348.58%   |
| 2024-09-30   | $0.43B     | 169.43%   |
| 2024-06-30   | $0.12B     | 594.31%   |
| 2024-03-31   | $0.23B     | 296.96%   |

**Analysis:**

*   **Revenue:** Revenue shows a slightly decreasing trend over the quarters.
*   **Profit Margin:** Profit margins have remained relatively stable, hovering around 60%.
*   **Equity:** Equity has fluctuated.
*   **ROE:** Return on Equity (ROE) is very high and fluctuates significantly, possibly indicating volatility in profitability relative to equity.

**7. Overall Summary:**

Colgate-Palmolive (CL) is currently exhibiting several concerning trends:

*   **Underperformance:**  Significantly underperforming the S&P 500.
*   **Negative Momentum:** Recent price action and moving averages suggest negative short-term momentum.
*   **Weak Technicals:** Hybrid signal, PPO. While the RSI is oversold, it alone isn't enough to suggest a strong buy signal.
*   **Decreasing Revenue:** Revenue has been declining slightly.
*   **High ROE volatility:** High ROE values indicate volatility in profitability relative to equity.
*   **Extremely Negative Expected Return:** The projected very negative expected return raises significant concerns, it should be investigated further as it can indicate an error in the source of the data.

**Recommendation:** Based on the provided data, a cautious approach to Colgate-Palmolive is warranted. The company faces challenges in terms of market performance, revenue growth, and potential profitability concerns. Investors should carefully monitor future earnings reports, company announcements, and industry trends. While the oversold RSI suggests a potential short-term rebound, the overall picture is not particularly encouraging.
